Package 65219-586-04

Brand: tyenne

Generic: tocilizumab-aazg
NDC Package

Package Facts

Identity

Package NDC 65219-586-04
Digits Only 6521958604
Product NDC 65219-586
Product ID 65219-586_90995548-9bf5-42ce-a93f-26b51a58044d
Description

1 SYRINGE, GLASS in 1 CARTON (65219-586-04) / .9 mL in 1 SYRINGE, GLASS

Marketing

Marketing Status
Discontinued 2027-12-31
Brand tyenne
Generic tocilizumab-aazg
Sample Package No

Linked Drug Pages (1)

TYENNE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "90995548-9bf5-42ce-a93f-26b51a58044d", "openfda": {"nui": ["N0000190478", "N0000190480"], "upc": ["0365219586043"], "unii": ["I031V2H011"], "rxcui": ["2686045", "2686050", "2686053", "2686057"], "spl_set_id": ["ad76441d-da59-47df-8d9d-2243005180f0"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (65219-586-04)  / .9 mL in 1 SYRINGE, GLASS", "package_ndc": "65219-586-04", "marketing_end_date": "20271231", "marketing_start_date": "20240701"}], "brand_name": "TYENNE", "product_id": "65219-586_90995548-9bf5-42ce-a93f-26b51a58044d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "65219-586", "generic_name": "Tocilizumab-aazg", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TYENNE", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "162 mg/.9mL"}], "application_number": "BLA761275", "marketing_category": "BLA", "marketing_start_date": "20240701", "listing_expiration_date": "20261231"}